share_log

Short Interest in EFFECTOR Therapeutics, Inc. (NASDAQ:EFTRW) Decreases By 23.9%

kopsource ·  Jan 3, 2023 10:51

eFFECTOR Therapeutics, Inc. (NASDAQ:EFTRW – Get Rating) was the recipient of a significant decline in short interest in December. As of December 15th, there was short interest totalling 26,800 shares, a decline of 23.9% from the November 30th total of 35,200 shares. Based on an average daily volume of 16,000 shares, the short-interest ratio is presently 1.7 days.

eFFECTOR Therapeutics Price Performance

EFTRW remained flat at $0.16 during midday trading on Monday. eFFECTOR Therapeutics has a 1-year low of $0.04 and a 1-year high of $0.99. The stock has a fifty day moving average of $0.13 and a 200 day moving average of $0.17.

Recommended Stories

  • Get a free copy of the StockNews.com research report on eFFECTOR Therapeutics (EFTRW)
  • MarketBeat: Week in Review 12/26 – 12/30
  • The Dogs Of Tech: It's Time For A Bite Of These Stocks
  • Does This Acquisition Make Microsoft a Bear Market Buy?
  • Should You Warm up to Generac Stock for the Winter?
  • Is Kintara Therapeutics A Hidden Gem?

Receive News & Ratings for eFFECTOR Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for eFFECTOR Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment